About Rheo Pharma Private Limited
Data last updated:
Rheo Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2019PTC136445. Its GSTIN is 36AAJCR8840D1Z7 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Lakshmi Yarramreddy (Managing Director) and Yarramreddy Ramesh Reddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.46 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹24.04 Lakh (net margin 3.7%) and EBITDA of ₹33.77 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 189% over three years.
For more details, the company can be reached via its website rheopharma.com.
Company details
Contact details
Rheo Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is rheopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address7 – 1 – 618/Atc/501, 5th Floor Aditya Trade Centre, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rheo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Rheo Pharma are trade and professional, scientific and technical. In detail, this covers wholesale trading and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Rheo Pharma Private Limited, buy the company report.
Financials of Rheo Pharma Private Limited
FY 2024 filings availableRheo Pharma Private Limited reported revenue of ₹6.46 Cr (up 525% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 189% over three years, including 525% growth in the latest year. EBITDA rose 216% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rheo Pharma Private Limited, buy the company report.
Board of directors of Rheo Pharma Private Limited
Rheo Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yarramreddy Ramesh Reddy | Director | 01 Nov 2020 | 5 Years 11 Months | Current |
| Lakshmi Yarramreddy | Managing Director | 29 Oct 2019 | 6 Years 11 Months | Current |
Peer comparison
Rheo Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bravo Pharmaceuticals Private Limited | ₹6.47 Cr (FY 2024) | 750.0% | New Delhi, Delhi, India | |||
| Wasazra Pharmaceuticals Limited | ₹6.46 Cr (FY 2024) | -2.0% | Lucknow, Uttar Pradesh, India | |||
| Rheo Pharma Private Limitedthis company | ₹6.46 Cr (FY 2024) | ₹24.04 Lakh | 3.7% | 525.0% | Hyderabad, Telangana, India | |
| Tejaswi Biotech Private Limited | ₹6.43 Cr (FY 2025) | -25.0% | Delhi, India | |||
| Lifecom Prima (India) Private Limited | ₹6.43 Cr (FY 2024) | 17.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Rheo Pharma Private Limited, buy the company report.
Auditor
Rheo Pharma Private Limited is audited by V R MORA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V R MORA & ASSOCIATES | FY 2023 | 227424 |
Shareholding
The shareholding of Rheo Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Rheo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rheo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rheo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rheo Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCR8840D1Z7 | Telangana | Active | 10 Dec 2019 |
To see the full GST registrations and return filing status of Rheo Pharma Private Limited, buy the company report.
Recent activity
Rheo Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Andra Anusha ceased to be Director on 01 May 2025.
Frequently asked questions
Rheo Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 October 2019 (7+ years old) and is registered under CIN U24299TG2019PTC136445.
Rheo Pharma has 2 current directors:
- Lakshmi Yarramreddy - Managing Director
- Yarramreddy Ramesh Reddy - Director
The latest financial statements of Rheo Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Rheo Pharma is 36AAJCR8840D1Z7, registered in Telangana.
The CIN (Corporate Identification Number) of Rheo Pharma is U24299TG2019PTC136445. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rheo Pharma was incorporated on 29 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rheo Pharma by revenue are Bravo Pharmaceuticals Private Limited, Wasazra Pharmaceuticals Limited, Tejaswi Biotech Private Limited, Lifecom Prima (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Andra Anusha ceased to be Director on 01 May 2025. Jyothsna Madhuri Rompicharla ceased to be Director on 01 Nov 2020. Yarramreddy Ramesh Reddy was appointed as Director on 01 Nov 2020. Rheo Pharma has 4 board changes on record in total.
Rheo Pharma can be reached through the website rheopharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Rheo Pharma is at 7 – 1 – 618Atc501, 5th Floor Aditya Trade Centre, Hyderabad, Telangana, India – 500038.
Rheo Pharma operates in the pharma industry, in the drug formulation and development segment.